GESTIÓN EN SALUD PÚBLICA: FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins | FDA

martes, 20 de julio de 2021

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins | FDA

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)